These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Thrombocytopenia in the antiphospholipid syndrome: pathophysiology, clinical relevance and treatment. Galli M; Finazzi G; Barbui T Ann Med Interne (Paris); 1996 Sep; 147 Suppl 1():24-7. PubMed ID: 8952756 [TBL] [Abstract][Full Text] [Related]
7. Primary antiphospholipid antibody syndrome presenting with encephalopathy, psychosis and seizures. Taipa R; Santos E Lupus; 2011 Nov; 20(13):1433-5. PubMed ID: 21768180 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of antiphospholipid antibodies in patients with neurological symptoms. Miesbach W; Gilzinger A; Gökpinar B; Claus D; Scharrer I Clin Neurol Neurosurg; 2006 Feb; 108(2):135-42. PubMed ID: 16412834 [TBL] [Abstract][Full Text] [Related]
9. Neurologic symptoms as a feature of the antiphospholipid syndrome. Miesbach W Semin Thromb Hemost; 2008 Apr; 34(3):286-9. PubMed ID: 18720309 [TBL] [Abstract][Full Text] [Related]
10. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
11. Cerebral manifestations in the antiphospholipid (Hughes) syndrome. Sanna G; D'Cruz D; Cuadrado MJ Rheum Dis Clin North Am; 2006 Aug; 32(3):465-90. PubMed ID: 16880079 [TBL] [Abstract][Full Text] [Related]
12. Antiphospholipid antibodies and migraine: a retrospective study of 428 patients with inflammatory connective tissue diseases. Tănăsescu R; Nicolau A; Caraiola S; Ticmeanu M; Cojocaru IM; Frăsineanu A; Ionescu R; Hristea A; Ene A; Anghel D; Tănăsescu R; Băicuş C Rom J Intern Med; 2007; 45(4):355-63. PubMed ID: 18767411 [TBL] [Abstract][Full Text] [Related]
13. [Neurological manifestations of the antiphospholipid syndrome]. Suárez Alvarez L; Hughes GR; Khamashta MA Med Clin (Barc); 2005 Apr; 124(16):630-3. PubMed ID: 15871782 [TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid antibodies: lessons from the bench. Koike T; Bohgaki M; Amengual O; Atsumi T J Autoimmun; 2007; 28(2-3):129-33. PubMed ID: 17383159 [TBL] [Abstract][Full Text] [Related]
15. New subsets of the antiphospholipid syndrome in 2006: "PRE-APS" (probable APS) and microangiopathic antiphospholipid syndromes ("MAPS"). Asherson RA Autoimmun Rev; 2006 Dec; 6(2):76-80. PubMed ID: 17138247 [TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid syndrome: role of antiphospholipid antibodies in neurology. Dafer RM; Biller J Hematol Oncol Clin North Am; 2008 Feb; 22(1):95-105, vii. PubMed ID: 18207068 [TBL] [Abstract][Full Text] [Related]
17. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. Danowski A; de Azevedo MN; de Souza Papi JA; Petri M J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935 [TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals. Girón-González JA; García del Río E; Rodríguez C; Rodríguez-Martorell J; Serrano A J Rheumatol; 2004 Aug; 31(8):1560-7. PubMed ID: 15290736 [TBL] [Abstract][Full Text] [Related]
20. Hughes syndrome, the antiphospholipid syndrome: a new chapter in neurology. Sanna G; Bertolaccini ML; Hughes GR Ann N Y Acad Sci; 2005 Jun; 1051():465-86. PubMed ID: 16126988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]